Title |
Ypač sunkaus širdies nepakankamumo medikamentinis recipientų gydymas / |
Translation of Title |
The importance of medical treatment for patients waiting for heart transplantation. |
Authors |
Žemaitaitytė, Gitana ; Miniauskas, Saulius ; Ručinskas, Kęstutis ; Maneikienė, Vytė Valerija ; Zorinas, Aleksejus ; Čibiras, Sigitas Vladas ; Laucevičius, Aleksandras ; Sirvydis, Vytautas-Jonas |
DOI |
10.15388/LietChirur.2007.3.2228 |
Full Text |
|
Is Part of |
Lietuvos chirurgija.. Vilnius : Vilniaus universiteto leidykla. 2007, t. 5, Nr. 3, p. 465-468.. ISSN 1392-0995 |
Keywords [eng] |
medical treatment ; heart failure ; transplantation |
Abstract [eng] |
Heart failure problems have been grovving worldwide, despite the fact that prevention and the most modern treatment methods are being applied. According to the data provided by the European Society of Cardiology in 2005, about 14 mill. Europeans suffer from heart failure, and the prognosis for 2020 covers 30 mill. people. This is a more than a two-fold increase over the coming 15 years. In Lithuania, 54.4% of all deaths in 2005 occurred as a result of cardiovascular diseases. The most threatening fact is that 33% of them are 45-64 years old, i.e. were in their most creative and employable age. At the Vilnius University Heart Surgery Centre, heart failure is treated both medically and surgically. When all the traditional medical treatment is insufficient, the last hope to help the patients is heart transplant. Heart transplantation was started at the VU Heart Surgery Centre in 1987. Until 2007, 47 transplant operations were performed. Over the first 13 years, 19 (11%) operations were performed. Over the last five years the scope of medical treatment has increased due to ACE inhibitors, diuretics, BAB, aldosterone antagonists, glycosides; sometimes medicines with a positive inotropic effect are administered (dopamine, dobutamine, levosimendane), which resulted in a three-fold number of heart transplantation operations. Patients suffering from heart failure and waiting for heart transplantation now live up to 3 years, while earlier only 1 % of recipients on the waiting list lived more than 12 months. The results prove that the constant application of modern medical treatment increases the number of last-stage heart failure patients who may hope to receive donors. |
Published |
Vilnius : Vilniaus universiteto leidykla |
Type |
Journal article |
Language |
Lithuanian |
Publication date |
2007 |
CC license |
|